å瀟ã®è²¡åç¶æ³ã¯æ¯èŒçå¥å šã§ããåç€Ÿã®æ ªäŸ¡ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸãããŸããæ©é¢æè³å®¶ã«ããèªç¥åºŠã¯éåžžã«é«ãã§ããéå»30æ¥éã§ãè€æ°ã®ã¢ããªã¹ããå瀟ãããŒã«ããšè©äŸ¡ããŸãããåžå Žã§ã®ããã©ãŒãã³ã¹ã¯éåžžã«äœèª¿ã§ããããã¡ã³ãã¡ã³ã¿ã«ãºãšãã¯ãã«ã«ã¯å 調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
å瀟ã®çŸåšã®è²¡åã¹ã³ã¢ã¯7.40ã§ããã«ã¹ã±ã¢ãããã€ã㌠& ãµãŒãã¹æ¥çã®å¹³å7.42ãããäœãæ°Žæºã§ãã 財åç¶æ³ã¯å®å®ã§ã ãŸããäºæ¥å¹çã¯é«ãã§ãã ææ°ååæã®åçã¯181.33Mã§ãåå¹Žåææ¯10.23%ã®å¢å ã§ãããäžæ¹ãçŽå©çã¯åå¹Žåææ¯141.88%ã®å¢å ã§ããã
å瀟ã®çŸåšã®ããªã¥ãšãŒã·ã§ã³ã¹ã³ã¢ã¯1.20ã§ããã«ã¹ã±ã¢ãããã€ã㌠& ãµãŒãã¹æ¥çã®å¹³å2.35ãããäœãæ°Žæºã§ãã çŸåšã®PERïŒæ ªäŸ¡åççïŒã¯-9.94ã§ãçŽè¿é«å€-14.51ã45.92%äžåããçŽè¿å®å€-22.05ã-121.85%äžåã£ãŠããŸãã
å瀟ã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯6.93ã§ããã«ã¹ã±ã¢ãããã€ã㌠& ãµãŒãã¹æ¥çã®å¹³å7.58ãããäœãæ°Žæºã§ãã Neogenomics Incã®å¹³åç®æšæ ªäŸ¡ã¯11.00ã§ãæé«ã¯14.00ãæäœã¯3.50ã§ãã
å 責äºé ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
å瀟ã®çŸåšã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯8.85ã§ããã«ã¹ã±ã¢ãããã€ã㌠& ãµãŒãã¹æ¥çã®å¹³å6.88ãããé«ãæ°Žæºã§ãã æšªã°ã: çŸåšãæ ªäŸ¡ã¯æµæç·9.47ãšæ¯æç·6.35ã®éã§æšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
æ¬ææšæ©èœã¯ãåçš®ãã¯ãã«ã«ææšãçšããŠéèååã®æ°å€åæãšæ¹åæ§è©äŸ¡ãæäŸããæè¡çãªèŠçŽã衚瀺ããŸãã
æ¬æ©èœã§ã¯MACDã»RSIã»KDJã»StochRSIã»ATRã»CCIã»WRã»TRIXã»MAã®9çš®é¡ã®äž»èŠãã¯ãã«ã«ææšãç¶²çŸ ããŠããŸããæé軞ã¯ãèªèº«ã®ããŒãºã«åãããŠèª¿æŽå¯èœã§ãã
ãã¯ãã«ã«åæã¯æè³å€æã®äžèŠçŽ ã«éãããæ°å€ã«ããæ¹åæ§è©äŸ¡ã«çµ¶å¯Ÿçãªåºæºã¯ãããŸãããè¡šç€ºçµæã¯ãããŸã§åèæ å ±ã§ãããææšèšç®ã»èŠçŽã®æ£ç¢ºæ§ã«ã€ããŠåœæ¹ã¯è²¬ä»»ãè² ããããŸãã
å瀟ã®çŸåšã®æ©é¢æè³å®¶èªç¥åºŠã¹ã³ã¢ã¯10.00ã§ããã«ã¹ã±ã¢ãããã€ã㌠& ãµãŒãã¹æ¥çã®å¹³å8.03ãããé«ãæ°Žæºã§ãã ææ°ã®æ©é¢æè³å®¶ä¿ææ¯çã¯98.17%ã§ãåååææ¯3.88%ã®æžå°ãšãªããŸããã æå€§ã®æ©é¢æè³å®¶ã¯ãã³ã¬ãŒãã§ãåèš14.10Mæ ªïŒçºè¡æžæ ªåŒã®10.92%ïŒãä¿æããŠãããä¿ææ ªæ°ã¯1.40%æžå°ããŸããã
å瀟ã®çŸåšã®ãªã¹ã¯è©äŸ¡ã¹ã³ã¢ã¯3.06ã§ããã«ã¹ã±ã¢ãããã€ã㌠& ãµãŒãã¹æ¥çã®å¹³å4.17ãããäœãæ°Žæºã§ãã å瀟ã®ããŒã¿å€ã¯1.62ã§ãã ããã¯ãäžæçžå Žã§ã¯æ ªäŸ¡ãåžå Žå šäœïŒææ°ïŒãäžåãåŸåãããäžæ¹ã§ãäžèœçžå Žã§ã¯ãã倧ããªäžèœãçµéšããããšã瀺ããŠããŸãã